Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study's history now includes a new revision entry (v3.6.3), indicating an update to the record after the previous revision. The older revision (v3.6.2) appears as part of the former history and is superseded by the new entry.SummaryDifference0.1%

- Check23 days agoChange DetectedRecord History now includes a new revision entry (v3.6.2) and removes the older v3.6.0 entry, updating the versioning history of the study record.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Last verified and Last known status fields to the history view, enhancing traceability of when the record was verified and its latest status. Updated the revision tag to v3.6.0, replacing the prior v3.5.5 indicator.SummaryDifference2%

- Check45 days agoChange DetectedA new revision entry v3.5.5 was added to the study's history, indicating an updated version of the record. The prior revision v3.5.4 was removed from the visible history, affecting the sequence of past changes.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s revision label in the footer updated from v3.5.3 to v3.5.4, indicating a minor update to the record history.SummaryDifference0.1%

- Check81 days agoChange DetectedThe Record History shows a new revision, v3.5.3, replacing the previous v3.5.2, signaling an update to the record history. This indicates an update to the record history rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.